YolTech raises $70.0M (China, May 2026)
Find the investors funding Health rounds
326,000+ verified VCs, angels and family offices — direct emails, check sizes and stage filters.
Exclusive: China gene editing startup YolTech raises $70M to move CRISPR therapies forward - Endpoints News
YolTech is a gene editing startup focused on advancing CRISPR therapies. The company aims to develop innovative treatments in the field of genetic medicine and is preparing for a public offering in Hong Kong.
Exclusive: China gene editing startup YolTech raises $70M to move CRISPR therapies forward Endpoints News
| Sep 01, 2026 | Tripo AI | $410.0M | Series B | China |
| Aug 31, 2026 | Sharpa | $670.0M | — | China |
| Aug 31, 2026 | Wuxi Gongwang | $13.9M | Series A | China |
| Aug 31, 2026 | Dongxi Fusion | $42K | — | China |
11,302 investors back startups in China
You just read who funded YolTech. The same database has the investors behind every other round — with verified emails, check sizes and the stages they actually write at.
Free account: 5 investor contact unlocks a month, no card required.